Cargando…
Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is to blame for about 60% of dementia cases worldwide. The blood–brain barrier (BBB) prevents many medications for AD from having clinical therapeutic effects that can be used to treat the affected area. Many researchers have turned their attention to cell membrane biomimeti...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005336/ https://www.ncbi.nlm.nih.gov/pubmed/36903581 http://dx.doi.org/10.3390/molecules28052336 |